SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-293424
Filing Date
2019-11-15
Accepted
2019-11-15 16:15:03
Documents
4
Period of Report
2019-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d836248d8k.htm 8-K 21144
2 EX-1.1 d836248dex11.htm EX-1.1 188731
3 EX-5.1 d836248dex51.htm EX-5.1 8502
4 GRAPHIC g836248g1115012108220.jpg GRAPHIC 4407
  Complete submission text file 0001193125-19-293424.txt   225825
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 191224692
SIC: 2834 Pharmaceutical Preparations